Abualas, Ayeesha M.

HRN: 28-78-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/18/2026
06/28/2026
PO
4.5mL
Q8
Amoebiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: